Immunomodulation of FOXP3+ regulatory T cells by the aromatase inhibitor letrozole in breast cancer patients.
Generali D, Bates G, Berruti A, Brizzi MP, Campo L, Bonardi S, Bersiga A, Allevi G, Milani M, Aguggini S, Dogliotti L, Banham AH, Harris AL, Bottini A, Fox SB.
Generali D, et al.
Clin Cancer Res. 2009 Feb 1;15(3):1046-51. doi: 10.1158/1078-0432.CCR-08-1507.
Clin Cancer Res. 2009.
PMID: 19188178
Free article.